Cost-Effectiveness Analysis of Three Therapeutic Schemes in Treatment of Bronchopneumonia in Children
Bin Li
Abstract
Bin Li
Abstract
Objective: To investigate the pharmacoeconomics of 3 therapeutic schemes in treatment of bronchopneumonia in children.Method: The cost-effectiveness of cefotaxime sodium(A group),penicillin(B group) and Cephazolin sodium(C group) in treatment of bronchopneumonia in children was analysed retrospectivly.Result: The cost of A,B,C group were 2291.00 yuan,2079.94 yuan and 2214.40 yuan respectively,and their total effective rate were 92.86%,85.71% and 88.10%(P0.05) respectively.The ratio of cost-effectiveness were 24.67,24.26 and 25.13.The sensitiveness analysis showed the results was reliable.Conclusion: The therapeutic schemes of gorup B was best.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To investigate the pharmacoeconomics of 3 therapeutic schemes in treatment of bronchopneumonia in children.Method: The cost-effectiveness of cefotaxime sodium(A group),penicillin(B group) and Cephazolin sodium(C group) in treatment of bronchopneumonia in children was analysed retrospectivly.Result: The cost of A,B,C group were 2291.00 yuan,2079.94 yuan and 2214.40 yuan respectively,and their total effective rate were 92.86%,85.71% and 88.10%(P0.05) respectively.The ratio of cost-effectiveness were 24.67,24.26 and 25.13.The sensitiveness analysis showed the results was reliable.Conclusion: The therapeutic schemes of gorup B was best.
Key concepts: Medicine, Bronchopneumonia, Pharmacoeconomics, Cefotaxime, Penicillin, Antibiotics, Internal medicine, Intensive care medicine